Photobiomodulation is one of the more heavily studied areas in at-home wellness technology — and also one of the most oversold. These articles walk through what the published research supports, where the evidence is thinner than the marketing, and how to read a spec sheet without being fooled by a big LED count.
The short version: certain wavelengths of red and near-infrared light pass through skin and are absorbed by structures inside the cells underneath. The most studied absorber is cytochrome c oxidase, an enzyme that sits at the end of the mitochondrial respiratory chain — the part of the cell that produces usable energy.
The leading hypothesis is that light absorption at that site briefly changes how efficiently the enzyme works, which nudges cellular energy production and sets off a cascade of secondary signals. That cascade — not the light itself — is what researchers are actually measuring when they study circulation, inflammatory markers or tissue repair.
Two properties decide whether any of this happens in practice. Wavelength determines how deep the light reaches: around 660nm is absorbed close to the surface, while 850nm penetrates further into tissue. Dose — irradiance multiplied by time — determines whether you land in the range where anything measurable occurs.
Dose is where most consumer devices fall down, in both directions. Too little and nothing happens. Too much and the effect can plateau or reverse, a pattern researchers call the biphasic dose response. It is the single most important idea on this page, and the reason a device with four times the LEDs is not four times better.
Written to be useful whether or not you buy anything from us — including the parts that argue against a purchase.
Red light is absorbed close to the surface; near-infrared reaches further in. Most single-wavelength devices quietly pick a side. What the penetration-depth research says about running both at once, and when one is genuinely enough.
The most counter-intuitive finding in the field: past a certain dose, benefits flatten and can reverse. How to think about irradiance, distance and session length — and why the "more LEDs" arms race misses the point entirely.
LED count, wavelength, irradiance at distance, and which of those numbers a manufacturer can inflate without technically lying. A practical guide to comparing devices, including ours, on the figures that actually matter.
Studies in this area tend to measure delayed-onset soreness, perceived exertion and specific blood markers. A look at what has been tested, in whom, and how far those results reasonably generalise to someone using a pad at home.
Local circulation increases have been reported using laser-Doppler measurement in multiple studies. What that measurement captures, what it doesn't, and why it's a mechanism rather than an outcome you should expect to feel.
Skin is where the research base is deepest, largely because outcomes are easy to photograph and score. What controlled studies have shown on texture and fine lines, over what timeframes, and how large the effects actually were.
Why joints are the hardest area to study well, what the range-of-motion literature reports, and the reason coverage geometry — how evenly light reaches a curved surface — matters more here than raw output.
The honest answer is that studies measuring visible change tend to run 8 to 12 weeks. What that means for the first fortnight, why consistency beats session length, and how to tell whether it's working for you.
Red light therapy is non-invasive and non-ablative, which is not the same as risk-free for everyone. Pregnancy, photosensitizing medication, implanted devices, eye exposure and diagnosed conditions — where to check before you start.
Blue light has the stronger acne evidence. Red light does something different, and smaller, than most product pages suggest — here's the honest division of labour.
Low-level laser therapy has real trial data for pattern hair loss — using devices built very differently from a skin panel. What the research actually covers, and what it doesn't.
Some of the oldest photobiomodulation research is on wound healing — most of it in clinical settings very different from a home routine.
The theory is straightforward — light exposure affects melatonin. The evidence for a home red light device is considerably thinner than the theory.
Back pain research spans nerve-mediated, muscular and disc-related causes — which is exactly why blanket claims about it are hard to trust.
Much of the reported relief may come from a mechanism red light shares with a simple heating pad — which matters for what you should expect.
Bright light boxes for seasonal mood are a completely different technology from red and near-infrared panels — and they are not interchangeable.
This is the corner of red light marketing with the thinnest evidence, and the most confident claims. Here's why it deserves extra skepticism.
No articles in that topic yet.
A page like this is usually written to sell you something. Here is the other half, which we think is a better reason to trust the first half.
Nothing in the consumer photobiomodulation literature supports using a home device in place of medical care. If you have a diagnosis, the device is at most something to raise with the person treating you.
The field has volume but a lot of it is small-sample, short-duration or laboratory work. "3,000+ studies" describes a large literature, not 3,000 large randomised trials in people like you.
Wavelength, irradiance, distance and duration differ enormously across the research, which makes results hard to compare and harder still to map onto any specific consumer product.
Everything on this page describes the published field, not a study of our hardware. We build to the wavelengths and dose ranges the research uses most — that is a design decision, not a clinical claim.
Four questions, about thirty seconds, and an honest answer — including when the answer is that none of them are right for you.
Take the fit quiz